---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-174885"
form_type: "8-K"
ticker: "COGT"
cik: "0001622229"
company_name: "Cogent Biosciences, Inc."
filed_at: "2022-06-15T23:59:59+00:00"
generated_at: "2026-06-25T01:37:19.018704+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cogent Biosciences raises ~$162M in underwritten public offering of common stock and pre-funded warrants

## Summary
- Offering of 15,169,698 shares at $8.25 per share plus pre-funded warrants for 3,030,302 shares at $8.24.
- Underwriters exercised option to purchase an additional 2,730,000 shares on same terms.
- Gross proceeds of approximately $162 million before underwriting discounts and expenses.
- Pre-funded warrants exercisable immediately; holder cannot exceed 9.99% beneficial ownership without notice.
- Offering made under effective shelf registration statement filed May 24, 2022.

## SEC filing metadata
- accession: 0001193125-22-174885
- form_type: 8-K
- ticker: COGT
- cik: 0001622229
- company_name: Cogent Biosciences, Inc.
- filed_at: 2022-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622229/000119312522174885/0001193125-22-174885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622229/000119312522174885/d256925d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-174885
- JSON: https://secwatch.observer/filing/0001193125-22-174885.json
- Plain text: https://secwatch.observer/filing/0001193125-22-174885.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.